Antitumor properties of vindesine-monoclonal antibody conjugatesROWLAND, G. F; AXTON, C. A; MARSDEN, C. H et al.Cancer immunology and immunotherapy. 1985, Vol 19, Num 1, pp 1-7, issn 0340-7004Article

Studies of methotrexate-monoclonal antibody conjugates for immunotherapyKANELLOS, J; PIETERSZ, G. A; MCKENZIE, I. F. C et al.Journal of the National Cancer Institute. 1985, Vol 75, Num 2, pp 319-332, issn 0027-8874Article

Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody = Effet antitumoral de l'actinomycine D encapsulé dans des liposomes portant des sous-unités de l'anticorps IgM monoclonal spécifique de la tumeurHASHIMOTO, Y; SUGAWARA, M; MASUKO, T et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5328-5334, issn 0008-5472Article

Monoclonal antibodies for targeting chemotherapeutic agentsBALDWIN, R. W.Progress in experimental tumor research. 1985, Vol 29, pp 140-151, issn 0079-6263Article

Systemic immunotoxin therapy of cancer : advances and prospectsWAWRZYNCZAK, E. J.British journal of cancer. 1991, Vol 64, Num 4, pp 624-630, issn 0007-0920Article

Immunopharmakologische Behandlung von 9 Digitaliswergiftungen bei Kindern mit Schaf-Antidigoxin Fab = Traitement immunopharmacologique des intoxications digitaliques chez 9 enfants avec de l'antidigoxine de moutons = Immunopharmacological treatment of digitalis intoxications in 9 children with sheep antidigoxinSMOLARZ, A; ABSHAGEN, U.Monatsschrift für Kinderheilkunde. 1985, Vol 133, Num 9, pp 682-687, issn 0026-9298Article

Antibody-drug conjugates for cancer therapyREISFELD, R. A; MUELLER, B. M; SCHRAPPE, M et al.Immunology and allergy clinics of North America. 1991, Vol 11, Num 2, pp 341-358, issn 0889-8561Article

International conference on monoclonal antibody immunoconjugates for cancerAntibody immunoconjugates, and radiopharmaceuticals. 1993, Vol 6, Num 1, pp 47-95, issn 0892-7049Conference Proceedings

Measures of renal function in patients with cisplatin-related chronic renal diseaseREED, E; JACOB, J; BRAWLEY, O et al.Journal of the National Medical Association. 1991, Vol 83, Num 6, pp 522-526, issn 0027-9684Article

Radiosensitizer conjugation to the carcinoma 19-9 monoclonal antibodyBORLINGHAUS, K. P; FITZPATRICK, D. A; HEINDEL, N. D et al.Cancer research (Baltimore). 1987, Vol 47, Num 15, pp 4071-4075, issn 0008-5472Article

The cellular uptake and cytoxicity of chlorambucilmonoclonal antibody conjugatesSMYTH, M. J; PIETERSZ, G. A; MCKENZIE, I. F. C et al.Immunology and cell biology. 1987, Vol 65, Num 4, pp 315-321, issn 0818-9641Article

Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clotMUZYKANTOV, V. R; SAKHAROV, D. V; SMIRNOV, M. D et al.Biochimica et biophysica acta. 1986, Vol 884, Num 2, pp 355-362, issn 0006-3002Article

Postoperative radiation therapy and adjuvant chemoimmunotherapy in breast cancer: aspects of timing and immune competenceKLEFSTROM, P; NUORTIO, L; TASKINEN, E et al.Acta radiologica. Oncology. 1986, Vol 25, Num 3, pp 161-166, issn 0349-652XArticle

INHIBITION OF A MOUSE HEPATOMA BY THE ALKYLATING AGENT TRENIMON LINKED TO IMMUNOGLOBULINSGHOSE T; GUCLU A; RAJA RAMAN R et al.1982; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1982; VOL. 13; NO 3; PP. 185-189; BIBL. 18 REF.Article

Cytokine therapeutics : lessons from interferon αGUTTERMAN, J. U.Proceedings of the National Academy of Sciences of the United States of America. 1994, Vol 91, Num 4, pp 1198-1205, issn 0027-8424Article

Clinical use of immunotoxins : monoclonal antibodies conjugated to protein toxinsRYBAK, S. M; YOULE, R. J.Immunology and allergy clinics of North America. 1991, Vol 11, Num 2, pp 359-380, issn 0889-8561Article

Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancerDURRANT, L. G; ROBINS, R. A; BALDWIN, R. W et al.Journal of the National Cancer Institute. 1989, Vol 81, Num 9, pp 688-696, issn 0027-8874Article

Cancer inflammatoire du sein: bilan à six ans de 16 malades traitées par immunochimiothérapie première = Inflammatory cancer of the breast: A review of 16 patients treated during a period of six years by primary immunochemotherapyZYLBERBERG, B; SALAT-BAROUX, J; RAVINA, J. H et al.Journal de gynécologie obstétrique et biologie de la reproduction. 1985, Vol 14, Num 4, pp 515-521, issn 0368-2315Article

Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediaryUMEMOTO, N; KATO, Y; TAKEDA, Y et al.Journal of applied biochemistry. 1984, Vol 6, Num 5-6, pp 297-307, issn 0161-7354Article

Targeting potential of antibody conjugatesEDWARDS, D. C.Pharmacology & therapeutics (Oxford). 1983, Vol 23, Num 1, pp 147-177, issn 0163-7258Article

Gemtuzumab ozogamicin (Mylotarg) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive diseaseNABHAN, C; RUNDHAUGEN, L; JATOI, M et al.Annals of oncology. 2004, Vol 15, Num 8, pp 1231-1236, issn 0923-7534, 6 p.Article

Divalent binding of monoclonal antibody to a cell surface antigen: modelling of equilibrium dataLARSSON, A.Molecular immunology. 1989, Vol 26, Num 8, pp 735-739, issn 0161-5890Article

Antibody-mediated targeting in the treatment and diagnosis of cancer: an overviewFORD, C. H. J; CASSON, A. G.Cancer chemotherapy and pharmacology. 1986, Vol 17, Num 3, pp 197-208, issn 0344-5704Article

Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapyWEBB, K. S; WARE, J. L; PARKS, S. F et al.Cancer treatment reports. 1985, Vol 69, Num 6, pp 663-672, issn 0361-5960Article

Conjugation of methotrexate to IgG antibodies and their F(ab')₂ fragments and the effect of conjugated methotrexate on tumor growth in vivoKULKARNI, P. N; HUNTLEY BLAIR, A; GHOSE, T et al.Cancer immunology and immunotherapy. 1985, Vol 19, Num 3, pp 211-214, issn 0340-7004Article